Mrudula Munagala

Medicine & Life Sciences

1. Heart-Assist Devices 100%
2. Heart Failure 68%
3. Ertapenem 50%
4. Takotsubo Cardiomyopathy 46%
5. Cefazolin 43%
6. Mortality 41%
7. Methicillin 40%
8. Salvage Therapy 40%
9. Heart Transplantation 35%
10. Patient Selection 35%
11. Transplant Recipients 31%
12. Staphylococcus aureus 29%
13. Liver Diseases 28%
14. Infections 26%
15. Transplants 25%
16. Chronic Disease 25%
17. Cardiovascular Diseases 24%
18. Hemorrhage 21%
19. Decision Making 19%
20. Immunosuppressive Agents 18%
21. Metabolomics 18%
22. Regeneration 17%
23. Biological Phenomena 16%
24. Computational Biology 15%
25. Proteomics 15%
26. Therapeutics 15%
27. Regenerative Medicine 14%
28. Morbidity 14%
29. Molecular Biology 13%
30. Research Design 13%
31. Cardiogenic Shock 13%
32. Organ Transplantation 12%
33. Graft Survival 11%
34. Bacteremia 11%
35. Cardiac Arrhythmias 9%
36. Medical Economics 9%
37. Hospital Mortality 9%
38. Transplantation 8%
39. Length of Stay 8%
40. Hospitalization 8%
41. Cardiac Resynchronization Therapy 8%
42. Equipment and Supplies 8%
43. International Classification of Diseases 7%
44. Inpatients 7%
45. Dilated Cardiomyopathy 7%
46. Cardiomyopathies 6%
47. Tissue Engineering 6%
48. Odds Ratio 6%
49. Myocardial Ischemia 5%
50. Epidemics 5%